Unlock the £1.4bn Healthcare Opportunity with Reclassification

Reclassifying medicines could unlock a £1.4bn opportunity to improve healthcare access and reduce pressure on the NHS, according to a new report. By expanding the range of medicines available over-the-counter (OTC), this strategic approach can empower patients to take more control of their own healthcare needs and free up valuable resources within the public health system.

The report, commissioned by the Proprietary Association of Great Britain (PAGB), the consumer healthcare association, highlights the significant potential benefits of reclassification - the process of moving a medication from prescription-only to over-the-counter (OTC) status. This shift not only improves accessibility for patients but also presents substantial cost savings for the National Health Service (NHS) and the broader economy.

"Reclassification can have a transformative impact on healthcare," said Michelle Riddalls, CEO of PAGB. "By empowering patients to self-manage more of their own conditions, we can ease the burden on the NHS and enable people to take a more active role in their wellbeing."

The report estimates that expanding reclassification could generate up to £1.4bn in savings for the NHS and the wider economy. This includes reduced GP consultations, fewer prescriptions, and lower costs for treating conditions that could be effectively managed with OTC medicines.

Furthermore, the increased availability of OTC medicines can improve access to treatments, particularly for those living in remote or underserved areas where access to a GP may be more challenging. This expanded access can contribute to better overall health outcomes and a more resilient healthcare system.

"Reclassification is a win-win for patients and the healthcare system," Riddalls added. "It's an opportunity to transform the way we deliver healthcare, putting more power in the hands of individuals and reducing the burden on our public services."

The report highlights several key areas where reclassification could have the most significant impact, including pain management, women's health, and the treatment of minor ailments. By making certain treatments more accessible, patients can receive the care they need more quickly and conveniently, while the NHS can focus its resources on more complex cases and urgent care.

As the healthcare landscape continues to evolve, the potential of reclassification to transform the system and improve patient outcomes is clear. By embracing this strategic approach, the UK can unlock a £1.4bn opportunity and pave the way for a more sustainable, patient-centric healthcare future.